Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lobb
Gail Lobb, Worcestershire GB
| Patent application number | Description | Published |
|---|---|---|
| 20090134104 | ROTARY CLOTHES LINE COVER - According to the present invention, there is provided a cover ( | 05-28-2009 |
Karen Lynn Lobb, Indianapolis, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20110263602 | TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS - The present invention provides novel tetrasubstituted pyridine hedgehog pathway antagonists of the following formula I (I) or a pharmaceutically acceptable salt thereof, wherein: X is C—R | 10-27-2011 |
Kenneth A. Lobb, Sammamish, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110296352 | ACTIVE CALIBRATION OF A NATURAL USER INTERFACE - A system and method are disclosed for periodically calibrating a user interface in a NUI system by performing periodic active calibration events. The system includes a capture device for capturing position data relating to objects in a field of view of the capture device, a display and a computing environment for receiving image data from the capture device and for running applications. The system further includes a user interface controlled by the computing environment and operating in part by mapping a position of a pointing object to a position of an object displayed on the display. The computing environment periodically recalibrates the mapping of the user interface while the computing environment is running an application. | 12-01-2011 |
Kenneth Alan Lobb, Sammamish, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110093820 | GESTURE PERSONALIZATION AND PROFILE ROAMING - A gesture-based system may have default or pre-packaged gesture information, where a gesture is derived from a user's position or motion in a physical space. In other words, no controllers or devices are necessary. Depending on how a user uses his or her gesture to accomplish the task, the system may refine the properties and the gesture may become personalized. The personalized gesture information may be stored in a gesture profile and can be further updated with the latest data. The gesture-based system may use the gesture profile information for gesture recognition techniques. Further, the gesture profile may be roaming such that the gesture profile is available in a second location without requiring the system to relearn gestures that have already been personalized on behalf of the user. | 04-21-2011 |
| 20110173574 | IN APPLICATION GESTURE INTERPRETATION - In a gesture-based system, gestures may control aspects of a computing environment or application, where the gestures may be derived from a user's position or movement in a physical space. A gesture-based system may have a plurality of modes, each mode a hardware configuration, a software configuration, or a combination thereof. Techniques for transitioning a user's control, via the user's gestures, between different modes enables a system to coordinate controls between multiple modes. For example, while a first mode is active, the user's gestures may control aspects of the first mode. The system may transition the user's control from a control of the first mode to a control of a second mode. The transition may be between hardware, software, or a combination thereof. In another embodiment, reserved gestures that correspond to a first mode that may be executed whether or not a second mode is present. | 07-14-2011 |
Roy Lobb, Westwood, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090324598 | METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS - A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1. | 12-31-2009 |
| 20110117073 | Protein Kinase Conjugates and Inhibitors - The invention relates to protein conjugates that contain a protein kinase containg a cysteine residue in the ATP binding site and an inhibitor that is covalently and irreversibly bonded to said cysteine residue, such that the activity of the protein kinase is irreversibly inhibited. The invention also relates to compounds that irreversibly inhibit protein kinases. | 05-19-2011 |
Roy R. Lobb, Westwood, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100203042 | RECOMBINANT ANTI-VLA4 ANTIBODY MOLECULES - The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation. | 08-12-2010 |